anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Hypoxia, a major issue in aquatic ecosystems, in special reference to climate change, and exacerbated by anthropogenic activities. It is causing slow growth, disease outbreaks, and mortality in finfish and shellfish. Therefore, adaptation to lowering oxygen levels through supplementation of herbs or their extracts in diets is imperative. In this study, hypoxia was simulated in controlled conditions with quercetin-enriched diets. Quercetin is a plant pigment (flavonol) possessing anti-oxidant property and is present in vegetables, leaves, seeds, pulses, and fruits. The experiment was conducted on rohu Labeo rohita, which is most widely cultured in India. There were four treatments including T1 (Normoxia: > 5 ppm dissolved oxygen; DO2), T2 (hypoxia: 3-4 ppm DO2), T3 (hypoxia + 50 mg quercetin/kg diet), and T4 (hypoxia + 100 mg quercetin/kg diet). The study was conducted for 30 days, and water quality was measured regularly. The results revealed that the hematological parameters were negatively affected. The tissue micro-architecture illustrated the impairment through degeneration of neurons in the brain, increased pigmentation as melanosis in the kidney, increased thickness of primary lamellae in the gills, and dilatations of sinusoids in the liver in hypoxia groups, while quercetin-enriched diets improved the hematological and histomorphological parameters. The results confirm the utility of hematological and histopathological tools as biomarkers and reflect the possible threats of hypoxia on fish. In conclusion, quercetin in diets appeared to show resistance towards chronic hypoxia by restoring the structure and functions of the vital organs towards normalcy and could be recommended as a potential ameliorative agent.
The invention discloses Cladosporium Sp. XJ-AC03 which is preserved in China center for type culture collection under the number of CCTCC NO.M2011483 on December 26 2011. A bacterial colony of the Cladosporium Sp. XJ-AC03 is circular with white regular edge. The bacterial colony is in milk white early in culture, and gradually turns gray to deep grayish green over time, and the center of the bacterial colony project slightly. Mycelia of the Cladosporium Sp. XJ-AC03 have transverse septa without longitudinal septa and are dense. Certain mycelia have conidiophore which is branched. The conidiophore is olivary with brown to dark brown color and is concentrated with 0-3 septa. The Cladosporium Sp. XJ-AC03 is obtained from root of Xinjiang Aconitum leucostomum by artificial separating and screening. The Cladosporium Sp. XJ-AC03 of aconitine can be synthesized effectively, and can be used as material for preparing antineoplastic drugs, anti-inflammatory drugs, and anti-rheumatic drugs.
INTRODUCTION AND OBJECTIVES: Delirium, recognized as a crucial prognostic factor in the cardiac intensive care unit (CICU), has evolved in response to the changing demographics among critically ill cardiac patients. This study aimed to create a predictive model for delirium for patients in the CICU.
METHODS: This study included consecutive patients admitted to the CICU of the Samsung Medical Center. To assess the candidate variables for the model: we applied the following machine learning methods: random forest, extreme gradient boosting, partial least squares, and Plmnet-elastic.net. After selecting relevant variables, we performed a logistic regression analysis to derive the model formula. Internal validation was conducted using 100-repeated hold-out validation.
RESULTS: We analyzed 2774 patients, 677 (24.4%) of whom developed delirium in the CICU. Machine learning-based models showed good predictive performance. Clinically significant and frequently important predictors were selected to construct a delirium prediction scoring model for CICU patients. The model included albumin level, international normalized ratio, blood urea nitrogen, white blood cell count, C-reactive protein level, age, heart rate, and mechanical ventilation. The model had an area under the receiver operating characteristics curve (AUROC) of 0.861 (95%CI, 0.843-0.879). Similar results were obtained in internal validation with 100-repeated cross-validation (AUROC, 0.854; 95%CI, 0.826-0.883).
CONCLUSIONS: Using variables frequently ranked as highly important in four machine learning methods, we created a novel delirium prediction model. This model could serve as a useful and simple tool for risk stratification for the occurrence of delirium at the patient's bedside in the CICU.
Minimally invasive biomarkers are urgently needed to detect molecular pathology in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Here, we show that plasma extracellular vesicles (EVs) contain quantifiable amounts of TDP-43 and full-length tau, which allow the quantification of 3-repeat (3R) and 4-repeat (4R) tau isoforms. Plasma EV TDP-43 levels and EV 3R/4R tau ratios were determined in a cohort of 704 patients, including 37 genetically and 31 neuropathologically proven cases. Diagnostic groups comprised patients with TDP-43 proteinopathy ALS, 4R tauopathy progressive supranuclear palsy, behavior variant FTD (bvFTD) as a group with either tau or TDP-43 pathology, and healthy controls. EV tau ratios were low in progressive supranuclear palsy and high in bvFTD with tau pathology. EV TDP-43 levels were high in ALS and in bvFTD with TDP-43 pathology. Both markers discriminated between the diagnostic groups with area under the curve values >0.9, and between TDP-43 and tau pathology in bvFTD. Both markers strongly correlated with neurodegeneration, and clinical and neuropsychological markers of disease severity. Findings were replicated in an independent validation cohort of 292 patients including 34 genetically confirmed cases. Taken together, the combination of EV TDP-43 levels and EV 3R/4R tau ratios may aid the molecular diagnosis of FTD, FTD spectrum disorders and ALS, providing a potential biomarker to monitor disease progression and target engagement in clinical trials.
The purpose of our study is to compare liver injury with dexmedetomidine. The enrolled patients were randomized into two group. In the study group, dexmedetomidine, diluted in 0.9% sodium chloride with the concentration of 4 ug ml-1 is administered with an loading dose of 0.5ug kg-1 of 10 min, and maintained with infusion rate of 0.5 ug kg-1 h-1. While, 0.9% sodium chloride serves as the placebo with the same loading dose and infusion rate in the control group. The infusion is ceased after the resection of the hepatic issues.

GST is a sensitive and specific marker for hepatic injury in several studies before and is taken as the primary endpoint. And the investigator use other inflammatory cytokines reflecting the systemic inflammatory response in serum. Besides these, the investigator observe the hemodynamic changes during the operation time and complications related with anesthesia and surgery.
FIELD: medicine, biotechnology. SUBSTANCE: invention relates to immunogenic composition containing chimeric HIV polypeptide, method for induction of immune response to HIV 1 and HIV 1/2, chimeric polypeptide HIV 1 and HIV 1/2, DNA molecule encoding chimeric polypeptide, plasmid vector for expression of chimeric polypeptide, polyclonal antibodies raised to HIV 1 or HIV 1/2 and diagnostic test-system for detection of antibodies raised to HIV 1 and HIV 2. Invention involves immunogenic composition based on chimeric polypeptides HIV 1 or HIV 1/2 representing full-sized protein p24 fused with immunodominant fragment gp 41 of site 575-616 or taken among them (rec 24-41) or fused with immunodominant fragment gp 36 of the same site or taken among them (rec 24-36). Indicated composition is able to induce the strong immune response to HIV 1 or HIV 2. Invention involves also the gene construction able to expression of indicated chimeric polypeptides in E. coli cells and diagnostic test-system for detection of antibodies raised to HIV 1 and HIV 2. The advantage of invention involves the development of gene construction allowing expression the chimeric recombinant protein that contains a full-sized polypeptide as a component of a single polypeptide chain and related by its conformation to viral protein p24 and immunogenic protein fragment of HIV 1 or HIV 2 envelope. Indicated recombinant proteins are able to induce strong immune response to HIV 1 or HIV 1/2 that allows using these chimeric polypeptides both for creation of diagnostic test-systems and for their recommendation for development of vaccine preparations. EFFECT: valuable properties of composition. 18 cl, 3 tbl, 5 dwg, 10 ex
In humans and mice, the induction of interleukin (IL)-17 expression enhances epithelial barrier integrity through the secretion of antimicrobial peptides (AMP), thereby improving antibacterial defense. However, it is unclear whether IL-17 has similar antibacterial effects in chickens by modulating the expression of AMPs, such as avian beta-defensins (also known as gallinacins) and cathelicidins. This study evaluated the in vivo effects of inoculating 20-day-old broiler chickens with two doses of a plasmid encoding chicken IL-17 (pCDNA3.1/rchIL-17-V5-HIS TOPO plasmid [pCDNA3.1-IL-17]; 5 or 10 μg/bird). On day 23 of age, all broilers, except those in the negative control group, were orally challenged with a virulent Clostridium perfringens strain for three days. To investigate IL-17-mediated effects against C. perfringens infection, the expression of avian beta-defensin 1 (avBD1), avBD2, avBD4, avBD6, cathelicidins, and inducible nitric oxide synthase (iNOS) genes were quantified, and gross necrotic enteritis (NE) lesion scores were assessed in the small intestine. The results showed that broilers receiving the higher dose of pCDNA3.1-IL-17 (10 μg) had significantly lower NE lesion scores compared to those receiving the lower dose (5 μg), the vector control, and the positive control groups. Furthermore, the expression of all avian beta-defensins and cathelicidin genes was detectable across all groups, regardless of treatment and time points. IL-17 treatment led to significantly higher expression of avBD1, avBD2, avBD4, avBD6, cathelicidin, and iNOS in the duodenum, jejunum, and ileum compared to control chickens. In C. perfringens-infected chickens, the expression of avBD1, avBD2, avBD4, cathelicidin, and iNOS in the ileum was significantly higher than in control chickens. Pre-treatment with the higher dose of pCDNA3.1-IL-17 (10 μg) in infected chickens was associated with reduced NE lesion severity and increased expression of avBD1, avBD2, cathelicidin, and iNOS in the ileum, but not avBD4 and avBD6. These findings provide new insights into the potential effect of IL-17 and reduction in NE lesion severity by modulating AMP expression which may be involved in mediating protective immunity against intestinal infection with C. perfringens.
The overweight and obesity epidemic affects approximately 1.6 millions of people worldwide. Obesity is a chronic condition, associated with premature death, co-morbidities, risk factors for main cardiac disease, stigmatization and significant economic costs. The causes of obesity are complex and include the interplay of environmental, social, economic and genetic factors. Besides fat-rich diets also play a significant role in the etiology of obesity. Correct diet orientation associated with physical exercise usually did not lead to expected result in weight loss and maintenance. Pharmacological therapy has been proposed as an adjunct to achieve the ideal weight. Orlistat acts in reduction of lipids absorption by inhibition of gastric and pancreatic lipases in gastrointestinal tract leading to sustained weight loss. This is a double blind study, randomized, of 2 weeks. The aim of this study was evaluate the intestinal lipase blockade by decrease of fat absorption of fecal fat after treatment with two commercials formulations of Orlistat in obese patients.
<P>PROBLEM TO BE SOLVED: To provide a liver-directed liposome composition comprising an oligonucleotide and its manufacturing method.  <P>SOLUTION: The liver-directed liposome composition comprises a complex of a liposome having a glycosylated cholesterol derivative as a constituting component and an oligonucleotide as an active ingredient. The glycosylated cholesterol derivative constituting the liposome composition comprises formula (1). In the formula, n is an integer of 1-10; G is a monosaccharide or a polysaccharide capable of binding to an asialoglycoprotein receptor; L is a linker; and L binds to the 1-position carbon of the sugar in G through -O- or -S-. By administering the liposome composition into the blood, an oligonucleotide including siRNA can be efficiently delivered to the liver.  <P>COPYRIGHT: (C)2007,JPO&INPIT
The optical impression system used for the study is TRIOS (3 shape). First of all, the operators in charge of taking the digital impressions are going to get trained prior the study and will calibrate (learning curve). MIS Scan bodies will be placed on the multi-unit plaforms, an x-ray will be taken in order to check the fit) and the impression will be realised following the instruction given by the system (first the maxillary and mandibular impressions followed by the bite registration). Shade will be chosen using VITA toothguide 3D master (to pick the right zirconia shade).
PURPOSE:To obtain a foamable bathing agent having prolonged foaming time and exhibiting excellent releasability from a mold in molding, by compounding a foamable bathing agent containing a carbonate and an organic acid with a specific powdery surfactant. CONSTITUTION:A foamable bathing agent containing a carbonate (e.g. sodium bicarbonate, sodium carbonate, etc.) and an organic acid (e.g. citric acid, malic acid, etc.) is compounded with (A) a powdery surfactant (having an average particle diameter of 1-1,000mum, especially 5-500mum) selected from (A) eagle wood saponin and (B) an amino acid-type surfactant such as N-acylsarcosine salt of N-acylglutamic acid salt having 8-22C acyl group. The amount of the surfactant is 0.1-10wt%, preferably 0.5-5wt% based on the whole composition. The addition of surfactant stabilizes the foaming performance of the agent in bath water and enables the continuous generation of carbon dioxide gas over a long period.
The evaluation of signs and symptoms of TMD was obtained from a Questionnaire (15) which includes information regarding difficulties opening the mouth and movement of the mandible, pains in the head, nape of the neck, neck or joint regions, noise in the temporomandibular joints, and the habit of clenching or grinding the teeth. The questionnaire is comprised of 10 questions with possible answers of yes (10 points), sometimes (5 points) and no (0 points). For each question, only one answer can be checked. The total score is used to classify the severity of the TMD as severe (70 to 100 points), moderate (45 to 65), mild (20 to 40) and no dysfunction (0 to 15).

The clinical (visual) assessment of head posture was conducted using a postural grid. Each subject was asked to remain in his or her normal posture, in a standing position. The self balance position was used to standardize the posture of each subject, asking them to look straight ahead, parallel to the floor, keeping the gaze horizontal
This part of the study will start with a very low dose of study drug, which will then be gradually increased in subsequent doses. This is known as dose-rising and is the way to assess safety and tolerability (i.e. possible presence of any side effects that make taking the drug unpleasant) of increasing the study drug. Effects will be compared to those seen when a placebo is taken. Up to 3 groups of 8 healthy male and female volunteers may be enrolled.
<P>PROBLEM TO BE SOLVED: To obtain a deodorant derived from a natural product, stably exhibiting excellent deodorant effects on various kinds of odorous substances, usable for deodorizing a wide range such as foods and drinks, feeds or various kinds of wastes and safely usable even by administration into a living body or application to the living body without adverse effects.  <P>SOLUTION: A yeast cell wall fraction obtained by removing soluble intramicrobial cell components from a yeast subjected to an enzymic treatment or a non-enzymic treatment is used as the deodorant for the various kinds of odorous substances. The deodorant is derived from the natural product and is safe and can safely be used even by administration into the living body or application to the living body. The odorous substances can be deodorized in the body or from the interior of the body by the administration or application without the adverse effects. The deodorant stably exhibits the deodorant effects on the various kinds of odorous substances and excellent deodorant effects can be obtained by the application to the wide range such as foods and drinks, feeds or various kinds of wastes.  <P>COPYRIGHT: (C)2006,JPO&NCIPI
In recent years, suicide prevention has received increased focus within the VA. This is in part related to concerns regarding the mental health and associated suicide risk of Operation Enduring Freedom/Operation Iraqi Freedom military personnel, and a recent study highlighting the increased risk of death by suicide for members of the veteran population. Suicide prevention initiatives could be greatly enhanced if a clinically feasible uniform language regarding suicidality and self-injury was readily available and adopted throughout the VA system. With this goal in mind, the Self-Directed Violence Classification System (SDVCS) and Clinical Tool were developed based upon the Centers for Disease Control and Prevention (CDC) nomenclature and VA VISN-19 MIRECC's work in this area. The purpose of this study is to evaluate whether a new standardized language for categorizing suicidal and self-injury related thoughts and behaviors can be readily adopted for use by mental health clinicians. Efforts also include developing a measure that can be used to help clinicians identify appropriate terms (e.g., behaviors) for specific patients.
An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN and FBS) has occurred in a few patients treated with lithium plus an antipsychotic. In some instances, the syndrome was followed by irreversible brain damage. Because of a possible causal relationship between these events and the concomitant administration of lithium and antipsychotics, patients receiving such combined therapy should be monitored closely for early evidence of neurologic toxicity and treatment discontinued promptly if such signs appear. This encephalopathic syndrome may be similar to or the same as neuroleptic malignant syndrome (NMS). 

Patients with bone marrow depression or who have previously demonstrated a hypersensitivity reaction (e.g., blood dyscrasias, jaundice) with a phenothiazine should not receive any phenothiazine, including prochlorperazine, unless in the judgment of the physician the potential benefits of treatment outweigh the possible hazards. 

Prochlorperazine may impair mental and/or physical abilities, especially during the first few days of therapy. Therefore, caution patients about activities requiring alertness (e.g., operating vehicles or machinery). 

Phenothiazines may intensify or prolong the action of central nervous system depressants (e.g., alcohol, anesthetics, narcotics).
Our previous studies revealed a novel link between gemcitabine (GEM) chemotherapy and elevated glutamine-fructose-6-phosphate transaminase 2 (GFPT2) expression in pancreatic cancer (PaCa) cells. GFPT2 is a rate-limiting enzyme in the hexosamine biosynthesis pathway (HBP). HBP can enhance metastatic potential by regulating epithelial-mesenchymal transition (EMT). The aim of this study was to further evaluate the effect of chemotherapy-induced GFPT2 expression on metastatic potential. GFPT2 expression was evaluated in a mouse xenograft model following GEM exposure and in clinical specimens of patients after chemotherapy using immunohistochemical analysis. The roles of GFPT2 in HBP activation, downstream pathways, and cellular functions in PaCa cells with regulated GFPT2 expression were investigated. GEM exposure increased GFPT2 expression in tumors resected from a mouse xenograft model and in patients treated with neoadjuvant chemotherapy (NAC). GFPT2 expression was correlated with post-operative liver metastasis after NAC. Its expression activated the HBP, promoting migration and invasion. Treatment with HBP inhibitors reversed these effects. Additionally, GFPT2 upregulated ZEB1 and vimentin expression and downregulated E-cadherin expression. GEM induction upregulated GFPT2 expression. Elevated GFPT2 levels promoted invasion by activating the HBP, suggesting the potential role of this mechanism in promoting chemotherapy-induced metastasis.
Participants will be given intravenous administration of sintilimab (200mg, q3w), cisplatin(75 mg/m², q3w) and Radiotherapy. After completing 2 cycles of concurrent chemoradiation, the Participants will continue to use 4 cycles of sintilimab (200mg, q3w) and cisplatin(75 mg/m², q3w) as maintenance therapy.
BACKGROUND & AIMS: Excess sucrose intake induces metabolic syndrome. In human, abnormal lipids metabolism like obesity, hyperlipidemia and fatty liver are induced. However, excess sucrose causes different phenotypes in different species. Based on our previous study, excess sucrose induced fatty liver and hyperlipidemia in rats. The phenotypes and mechanism of abnormal lipid metabolism in mice is unclear. We investigated the different phenotypes in 5 strains of mice and the relationship between gut microbiome and abnormal lipid metabolism in C57BL/6N mice.
METHODS: We examined the effect of a high sucrose diet in 5 different strains of mice. Besides, to find out the relationship between gut microbiome and metabolic disorder induced by excess sucrose, C57BL/6N mice were fed with a high sucrose diet with or without antibiotics cocktail.
RESULTS: A high sucrose diet induced obesity and fatty liver in inbred mice, whereas did not induce hyperlipidemia in all strains of mice. Moreover, a high sucrose diet changed the composition of gut microbiota in C57BL/6N mice. Antibiotics treatment alleviated the abnormal lipid metabolism induced by high sucrose diet by changing the composition of gut short chain fatty acids.
CONCLUSIONS: These results indicates that the phenotypes of metabolic syndrome are influenced by genetic factors. Furthermore, the dysbiosis of gut microbiome caused by excess sucrose may contribute to the development of abnormal lipid metabolism via its metabolites.
The students in the intervention group were subjected to acupressure on the right and left sides of Shenmen (HT7) acupuncture point of the heart meridian, Sanyinjiao (SP6) acupuncture point of the spleen meridian, Neiguan (PC6) acupuncture point of the pericardium point, and Tian-Zhu (BL10) acupuncture point of the neck. The researcher having the certificate practised acupressure on each point for two minutes each, totalling 16 minutes, three days a week for four weeks.